Alan M. Levine - Sep 1, 2023 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
/s/ Alan M. Levine
Stock symbol
AXGN
Transactions as of
Sep 1, 2023
Transactions value $
$0
Form type
4
Date filed
9/7/2023, 06:26 AM
Previous filing
Jun 5, 2023
Next filing
Jun 10, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Stock Option (right to purchase) Award $0 +20.4K $0.00 20.4K Sep 1, 2023 Common Stock 20.4K $6.30 Direct F1
transaction AXGN Restricted Stock Units Award $0 +11.9K $0.00 11.9K Sep 1, 2023 Common Stock 11.9K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting.
F2 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.